{"nct_id":"NCT00888108","title":"Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer","status":"COMPLETED","status_verified_date":"2012-05","start_date":"2009-07","start_date_type":null,"primary_completion_date":"2012-03","primary_completion_date_type":"ACTUAL","completion_date":"2012-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABT"]}